Global Lenalidomide Drug Market Size To Worth USD 21.47 Billion By 2033 | CAGR Of 5.69% [Yahoo! Finance]
Dr. Reddy's Laboratories Ltd (RDY)
US:NYSE Investor Relations:
drreddys.com/investors
Company Research
Source: Yahoo! Finance
Reach USD 21.47 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Celgene Corporation (Acquired by Bristol Myers Squibb), Natco Pharma Limited, Mylan N.V., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Sun Pharmaceutical Industries Ltd., LUPIN, Glenmark Pharmaceuticals, Accord Healthcare, Strides Pharma Science Limited, Hetero Drugs Limited, Teva Pharmaceutical Industries Ltd., Alkem Laboratories, Aurobindo Pharma Ltd., Novartis International AG., and other key companies. New York, United States , June 19, 2024 (GLOBE NEWSWIRE) -- The Global Lenalidomide Drug Market Size is to Grow from USD 12.34 Billion in 2023 to USD 21.47 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 5.69% during the projected period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4573 Lenalidomide is one therapy for adult myelodysplastic syndromes (MDS). This medication is also used to treat multiple myelom
Show less
Read more
Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RDY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RDY alerts
High impacting Dr. Reddy's Laboratories Ltd news events
Weekly update
A roundup of the hottest topics
RDY
News
- Dr. Reddy's to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business [Yahoo! Finance]Yahoo! Finance
- Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare BusinessBusiness Wire
- Haleon to sell overseas nicotine therapy business to Dr. Reddy's [Seeking Alpha]Seeking Alpha
- Active Pharmaceutical Ingredients (APIs) Market Size Expected to Reach USD 344.91 Billion by 2032 [Yahoo! Finance]Yahoo! Finance
- Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 [Yahoo! Finance]Yahoo! Finance
RDY
Earnings
- 5/8/24 - Beat
RDY
Sec Filings
- 6/28/24 - Form 6-K
- 6/28/24 - Form 6-K
- 6/26/24 - Form 6-K
- RDY's page on the SEC website